Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog Article
Pharma & Biotech
Multiomics takes centerstage at PMWC 2022
Our life science expert highlights a key insight from this year's Precision World Medicine Conference. From digital biomarkers to liquid biopsy, read how multiomics is becoming a central part of precision medicine
July 1, 2022
Blog Article
Pharma & Biotech
Multiomics takes centerstage at PMWC 2022
Our life science expert highlights a key insight from this year's Precision World Medicine Conference. From digital biomarkers to liquid biopsy, read how multiomics is becoming a central part of precision medicine
July 1, 2022
multiomics
Biomarkers
.png)
Newsletter Update
Pharma & Biotech
Digital Health | Q2 Update
We’ve rounded up the big headlines for you, from an Office of Inspector General data brief to exciting regulatory approvals, product launches, partnerships, and acquisitions in the digital health space.
July 1, 2022
Newsletter Update
Pharma & Biotech
Digital Health | Q2 Update
We’ve rounded up the big headlines for you, from an Office of Inspector General data brief to exciting regulatory approvals, product launches, partnerships, and acquisitions in the digital health space.
July 1, 2022
Medical Devices
Health Technology Market
Digital Health
DeciBio Q&A
Pharma & Biotech
The Next Frontier of Sensitivity: DeciBio’s Q&A with Stephane Mouradian of Personalis
DeciBio interviews Stephane Mouradian, Senior Vice President of BD & Marketing at Personalis, about the focus of the company moving forward and their highly sensitive NeXT Personal™ assay.
June 24, 2022
DeciBio Q&A
Pharma & Biotech
The Next Frontier of Sensitivity: DeciBio’s Q&A with Stephane Mouradian of Personalis
DeciBio interviews Stephane Mouradian, Senior Vice President of BD & Marketing at Personalis, about the focus of the company moving forward and their highly sensitive NeXT Personal™ assay.
June 24, 2022
MRD Testing
In The Press
Pharma Manufacturing - mRNA boom: A double-edged sword
Did short-term solutions for COVID-19 stifle long-term mRNA success?
June 23, 2022
In The Press
Pharma Manufacturing - mRNA boom: A double-edged sword
Did short-term solutions for COVID-19 stifle long-term mRNA success?
June 23, 2022
No items found.
DeciBio Q&A
Pharma & Biotech
DeciBio’s Peripheral Biomarkers Q&A with Dr. Ofer Sharon of OncoHost
In this Q&A, our experts interviewed Ofer Sharon, MD, MBA, is CEO and co-founder of OncoHost, a host response profiling company in the peripheral biomarkers space.
June 23, 2022
DeciBio Q&A
Pharma & Biotech
DeciBio’s Peripheral Biomarkers Q&A with Dr. Ofer Sharon of OncoHost
In this Q&A, our experts interviewed Ofer Sharon, MD, MBA, is CEO and co-founder of OncoHost, a host response profiling company in the peripheral biomarkers space.
June 23, 2022
Biomarkers
Proteomics Market
Digital Health
DeciBio Q&A
Pharma & Biotech
Next-Generation Programmable mRNA Therapies Post COVID-19 with Jacob Becraft of Strand Therapeutics
New Podcast Episode: DeciBio interviews Jacob Becraft, the CEO and co-founder of Strand Therapeutics.
June 22, 2022
DeciBio Q&A
Pharma & Biotech
Next-Generation Programmable mRNA Therapies Post COVID-19 with Jacob Becraft of Strand Therapeutics
New Podcast Episode: DeciBio interviews Jacob Becraft, the CEO and co-founder of Strand Therapeutics.
June 22, 2022
Next-Generation Therapeutics
Precision Medicine
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved